Alpha 2.0
Login Register
» Articles » PMID: 27539736

Relapsing Olmesartan-Associated Ileitis

Overview
Journal Ann Pharmacother
Specialty Pharmacology
Date 2016 Aug 20
PMID 27539736
Citations 4
Authors
Giuseppe Famularo
Giovanni Minisola
Affiliations
Soon will be listed here.
Citing Articles

Chronic diarrhoea, weight loss and a positive anti-tissue transglutaminase antibody: A case report of olmesartan-induced enteropathy.

Sheppard R, Evanson B, Campbell I, Shand A BMJ Case Rep. 2024; 17(5).

PMID: 38719261 PMC: 11085927. DOI: 10.1136/bcr-2023-255407.

Pharmacy and therapeutics committees strategy to address olmesartan safety issues at a primary care level.

Rovira-Illamola M, Pages-Puigdemont N, Sotoca-Momblona J, Mensa-Vendrell M, Barba-Avila O, Casasayas-Guilera M Int J Clin Pharm. 2020; 42(2):737-743.

PMID: 32078107 DOI: 10.1007/s11096-020-00993-7.

Association of sprue-like enteropathy and angiotensin receptor-1 antagonists.

Wenzel R, Datz C Wien Klin Wochenschr. 2019; 131(19-20):493-501.

PMID: 31471672 DOI: 10.1007/s00508-019-01539-2.

Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review.

Kamal A, Fain C, Park A, Wang P, Gonzalez-Velez E, Leffler D Gastroenterol Rep (Oxf). 2019; 7(3):162-167.

PMID: 31217979 PMC: 6573796. DOI: 10.1093/gastro/goz019.